Barbara Harlin Bispham sold $22K of Crescent Biopharma, Inc. (CBIO) stock

Barbara Harlin Bispham sold 1,218 shares of CBIO stock worth $22K, per an SEC Form 4 filed Jun 23, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 22, 2026, 1 day before it was made public.

CBIO has moved -7.5% since the trade date, from $17.57 to $16.25 (Sep 21, 2026 close).